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SUZ12 is a core component of the polycomb repressive
complex 2 (PRC2) and is required for the differentiation of
mouse embryonic stem cells (ESCs). PRC2 is associated
with transcriptional repression via methylation of H3 Lys-
27. We applied quantitative mass spectrometry to inves-
tigate the effects of Suz12 deficiency on H3.2 and H3.3
from mouse ESCs. Using high mass accuracy MS com-
bined with CID or electron transfer dissociation (ETD)
tandem mass spectrometry, we identified a total of 81
unique modified peptides from H3.2 and H3.3 and as-
signed 46 modifications at 22 different positions, includ-
ing distinct coexisting modifications. In certain cases,
high mass accuracy LTQ-Orbitrap MS/MS allowed pre-
cise localization of near isobaric coexisting PTMs such as
trimethylation and acetylation within individual peptides.
ETD MS/MS facilitated sequencing and annotation of
phosphorylated histone peptides. The combined use of
ETD and CID MS/MS increased the total number of iden-
tified modified peptides. Comparative quantitative analy-
sis of histones from wild type and Suz12-deficient ESCs
using stable isotope labeling with amino acids in cell
culture and LC-MS/MS revealed a dramatic reduction of
H3K27me2 and H3K27me3 and an increase of H3K27ac,
thereby uncovering an antagonistic methyl/acetyl switch
at H3K27. The reduction in H3K27 methylation and in-
crease in H3K27 acetylation was accompanied by H3K36
acetylation and methylation. Estimation of the global iso-
form percentage of unmodified and modified histone pep-
tides (amino acids 27–40) showed the relative distribution
of distinct coexisting histone marks. Our study revealed
limitations of antibody-based Western blotting methods
for detection of coexisting protein modifications and dem-
onstrated the utility of quantitative tandem mass spectro-
metry for detailed analysis of the dynamics of coexisting
post-translational modifications in proteins. Molecular &
Cellular Proteomics 9:838–850, 2010.
Histone proteins, H1, H2A, H2B, H3, H4, and their variants,
constitute the core of nucleosomes that organize DNA into
chromatin. Histones can be extensively modified, and various
post-translational modifications (PTMs)1 of histones have
been reported, including phosphorylation (ph), mono- (me1),
di- (me2), trimethylation (me3), acetylation (ac), formylation,
citrullination, and ubiquitylation (1–3). Most histone PTMs are
located within the N-terminal tails of histones, which contain
several basic residues such as lysines and arginines. Histone
PTMs influence the transcriptional activity of genes by affect-
ing chromatin structure via modulation of histone-DNA inter-
action. For instance, reduction of a positive charge on H4K16
upon acetylation leads to decompression of chromatin (4). In
addition, histone PTMs create or block the docking sites for
non-histone proteins, including transcription factors and epi-
genetic readers/writers/erasers (1, 5). For instance, H3K27
methylation has been suggested to be recognized by the
PRC1 complex, which results in RING1B (a component of the
PRC1 complex)-mediated ubiquitylation of H2A, thereby in-
ducing compaction of chromatin and stable repression of
genes (6–9).
An increasing amount of data suggests that PTMs of his-
tones are important for regulating transcription and that the
enzymes involved in this are required for proper differentiation
programs and development. For example, a bivalent regula-
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tory domain of H3 was identified by genome-wide location
analysis of histone marks in murine ESCs (10). The transcrip-
tionally active mark H3K4me3 was shown to co-localize with
the transcriptionally repressive mark H3K27me3 in promoter
regions of many key developmental genes in ESCs. These
“bivalent domains” silence developmental genes in ESCs and
resolve upon differentiation. Moreover, the combination of
different histone PTMs can affect the affinity of different
proteins toward histones and chromatin. For instance, the
14-3-3 protein, which binds to H3S10ph, increases its af-
finity when H3K14 becomes acetylated (11, 12). In contrast,
heterochromatin protein 1 (HP1) binds to H3K9me2/me3
and dissociates upon phosphorylation of the adjacent
H3S10 residue (13). In addition, several histone-modifying
enzymes have specificity for more than one amino acid
residue. Finally, cross-talk is observed where multivalent
modifications can act in concert to reinforce transcriptional
activation or repression (14): for instance, it was found that
asymmetric dimethylation on H3R2 in mammals inhibits
H3K4 trimethylation by MLL1, thereby repressing the tran-
scription of genes (15, 16).
Mass spectrometry-based approaches are advantageous
for mapping the combination of modifications in histones,
whereas antibody-based approaches, such as Western blot-
ting, are limited in detection of co-occurring PTMs in a protein
(17, 18). High mass accuracy mass analyzers such as the
FT-ICR mass analyzer or the orbitrap mass analyzer are very
useful in histone research as they allow distinguishing near
isobaric modifications such as acetylation (42.011 Da) and
trimethylation (42.047 Da) on lysine residues and accurate
annotate of coexisting PTMs. The recent advances in tech-
nologies for ion-electron reactions including electron capture
dissociation and electron transfer dissociation (ETD) methods
(19, 20) have improved MS/MS analysis and sequencing of
large peptides (2 kDa). These methods have been used in
histone research (21, 22).
Mass spectrometry-based proteomics allows identification
of modified peptides/proteins but also quantification of mod-
ified peptides via label-free (23) or isotope labeling methods
(24, 25). For example, Beck et al. (23) used a label-free LC-
MS/MS approach to quantify histone modifications upon
treatment of human cells with the histone deacetylase inhib-
itor PXD101 and demonstrated that acetylations on H2A,
H2B, H3, and H4 were affected by the PXD101 treatment.
Bonenfant et al. (24) used stable isotope labeling with amino
acids in cell culture (SILAC) (26) in conjunction with mass
spectrometry for quantification of histone modifications dur-
ing the cell cycle and measured changes in the global level of
histone modifications on all core histones. Moreover, mass
spectrometry-based methods have contributed in monitoring
the activity of enzymes responsible for adding or removing
modifications on histone proteins. LSD1, a nuclear amino
oxidase homologue, is the first lysine demethylase discov-
ered, and its demethylase activity was confirmed by analysis
of histone peptides by mass spectrometry (27). Histone-mod-
ifying enzymes play an important role in epigenetic regulations
(1, 28). SUZ12, together with EED and the SET domain-
containing protein EZH2, forms the core of the PRC2 com-
plex. EZH2 is a histone methyltransferase that catalyzes the
di- and trimethylation of H3K27. The three polycomb group
proteins of the PRC2 complex are all required for EZH2 his-
tone methyltransferase activity, and loss of either Suz12 or
Eed results in a global loss of H3K27me2 and -me3 (29, 30).
Importantly, the activity of the PRC2 complex is required for
development, stem cell differentiation, and epigenetic inher-
itance (8, 31–34). For example, loss of Suz12 causes embry-
onic death during early postimplantation stages, and the
Suz12-deficient embryos contain diminished levels of
H3K27me2 and H3K27me3 in vivo (34). However, little is
known about how the deletion of Suz12 affects PTMs in
addition to H3K27. Here, we demonstrate that SILAC and
tandem mass spectrometry using CID and ETD are suitable
methods for obtaining qualitative and quantitative information
of peptides with a single or a combination of PTMs from H3
variants upon inactivation of Suz12 in mouse ESCs.
EXPERIMENTAL PROCEDURES
Purification of Histones—Establishment of Suz12-deficient (KO)
ESCs was described previously (34). Suz12 KO mouse ESCs were
cultured for 6 days in SILAC Dulbecco’s modified Eagle’s medium
(Sigma) containing 15% dialyzed fetal bovine serum (Invitrogen), pen-
icillin-streptomycin (Invitrogen), nonessential amino acids (Invitrogen),
pyruvate (Invitrogen), 50 mM -mercaptoethanol, 3.5 g/liter D-glucose,
107 units/ml ESGRO leukemia inhibitory factor (Chemicon), 0.802 mM
L-leucine (Sigma), 0.398 mM L-arginine (Sigma), and 0.798 mM L-lysine
(Sigma). Lys8 isotope (Cambridge Isotopes, CNLM-291) was used for
the Suz12 KO ESCs. Histones were purified with a commercially
available histone purification kit (Active Motif, catalogue number
40025) according to the manufacturer’s instructions. Briefly, cells
were collected in acid extraction buffer with complete protease inhib-
itor mixture (Roche Applied Science, catalogue number
11873580001) and phosphatase inhibitor mixtures 1 and 2 (Sigma-
Aldrich, catalogue numbers P2850 and P5726) and kept at 4 °C for
1–2 h. After centrifugation for 5 min at 14,000 rpm, the supernatants
were collected, and pH was adjusted using loading buffer from the
histone purification kit. The samples were loaded onto a cation ex-
change column followed by washing with a low concentration NaCl
washing buffer. All histones were eluted in a single step using a high
concentration NaCl elution buffer from the histone purification kit.
Purified histones were precipitated overnight at 4 °C with 30% tri-
chloroacetic acid. Samples were then centrifuged at 14,000 rpm for
1 h and washed with acetone containing 0.2% HCl followed by a
second wash using 100% acetone. After air drying, the pellet was
resuspended in ddH2O.
Separation of Intact Histones by Reversed Phase HPLC—The con-
centration of purified histones was measured using the Q-bit analyzer
(Invitrogen). Heavy and light amino acid-labeled histones were mixed
in a 1:1 ratio, and a total of 200 g of histone mixture was separated
by reversed phase (RP) HPLC using a C18 column (250  2 mm,
Jupiter, 300 Å; Phenomenex, Torrance, CA) on an Akta-Basic system
(GE Healthcare). The A solvent consisted of 0.06% TFA in ddH2O, and
the B solvent was 0.04% TFA  90% ACN (Sigma). The HPLC
gradient increased from 5 to 35% in 10 min, 35 to 60% in 60 min, and
60 to 90% in 2 min.
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MALDI Analysis and Enzymatic Digestion—One microliter of each
histone fraction was mixed with 0.5 l of -cyano-4-hydroxycinnamic
acid (10 mg/ml in 70% ACN, 0.1% TFA) on the MALDI target, and the
intact masses of proteins were measured using MALDI-TOF MS
(Voyager-DE STR, Applied Biosystems) in the positive ion mode (data
not shown). All fractions were then freeze-dried and kept at 80 °C
until further analysis. Dried samples were then resuspended in 20 l
of 50 mM NH4HCO3, and endoproteinase Arg-C (Calbiochem) was
added (about 1:20 enzyme to protein ratio) and incubated at room
temperature for 2–6 h.
LC-MS/MS—Peptide mixtures were analyzed by LC-MS/MS using
an EasyLC instrument (Proxeon, Odense, Denmark) interfaced to an
LTQ-Orbitrap XL instrument (ThermoFisher Scientific, Bremen, Ger-
many). The nanoliter flow LC instrument was operated in a one-
column setup with a 25-cm analytical column (100-m inner diame-
ter, 350-m outer diameter) packed with C18 resin (ReproSil, Pur
C18AQ 3 m; Dr. Maisch). Solvent A was 0.1% formic acid in ddH2O,
and solvent B was 90% acetonitrile (Fisher Scientific) with 0.1%
formic acid. Samples were injected in an aqueous 1% TFA solution at
a flow rate of 550 nl/min. Peptides were separated with a gradient of
0–40% solvent B over 105–180 min followed by a gradient of 40–
60% for 15 min and 60–100% over 5 min at a flow rate of 250 nl/min.
The nanoelectrospray ion source (Proxeon) was used with a spray
voltage of 1.5–2.0 kV. No sheath, sweep, and auxiliary gasses were
used, and capillary temperature was set to 200 °C. The mass spec-
trometer was operated in a data-dependent mode to automatically
switch between MS and MS/MS acquisition. In the LTQ-Orbitrap,
full-scan MS spectra were acquired at a target value of 1  106 ions
with a resolution of 60,000 (full-width at half-height). Samples were
analyzed four times using four different MS/MS methods with a target
value of 1  104 ions or 4  104 ions for linear ion trap (LTQ) MS/MS
and 2  105 for orbitrap MS/MS. For CID MS/MS methods, singly
charged precursor ions were excluded. For ETD MS/MS methods,
singly and doubly charged precursor ions were excluded. The follow-
ing MS and MS/MS scan modes were used. 1) The five most intense
ions were isolated for fragmentation in the LTQ using CID with a
normalized collision energy setting of 35, and fragment ions were
scanned by the LTQ (CID-Hi/Low). 2) The three most intense ions
were isolated for fragmentation in the LTQ using CID with a normal-
ized collision energy value of 35, and fragment ions were scanned by
the orbitrap (CID-Hi/Hi). 3) The eight most intense ions were isolated
for fragmentation in the LTQ using ETD with an activation Q value of
0.25, activation time of 100 ms, and supplementary activation. Re-
sulting fragment ions were scanned by the LTQ (ETD-Hi/Low). 4) The
three most intense ions were isolated for fragmentation in the LTQ
using ETD with an activation Q value of 0.25, activation time of 100
ms, and supplementary activation. Resulting fragment ions were
scanned by the orbitrap (ETD-Hi/Hi). The dynamic exclusion time was
set to 40–60 s.
Data Analysis—The raw data from LTQ-Orbitrap were converted to
an mgf file using Proteome Discoverer 1.0 software (ThermoFisher
Scientific). Database searching was performed against a custom-
made database containing mouse histones retrieved from UniProt
release 14 using Mascot Daemon version 2.1.0 (Matrix Science).
Because of the small size of this database, we did not attempt to
calculate false discovery rates, nor did we pursue decoy database
searching. MS mass tolerance was set to 6 ppm for all files. Files
obtained with MS/MS scans by the LTQ (Hi/Low) were searched with
an MS/MS mass tolerance of 0.8 Da. Files obtained with MS/MS
scans by the orbitrap (Hi/Hi) were searched with an MS/MS mass
tolerance of 0.05 Da. CID data were searched with instrument setting
“ESI-trap,” and ETD data were searched with instrument setting
“ETD-trap.” Variable modifications included mono- and dimethylation
on lysine and arginine residues; trimethylation, acetylation, and
formylation on lysines; phosphorylation on serine, threonine, and
tyrosine; oxidation on methionine; and acetylation on the N terminus
of proteins. In addition, the same mgf file was searched with user-
defined modifications that included lysine modifications increased by
8.0142 Da (“heavy PTMs”) to take into account labeling of lysines with
stable isotopes. In this way, heavy isotope-labeled peptides with
PTMs were identified in the Mascot search. Mascot search results
were exported, and low confidence identifications were filtered using
Microsoft Office Excel 2007 with the following criteria: peptides with
a low score (cutoff score value, 15) and with many putative PTMs (5
PTMs/peptide) were removed. Redundant peptides were filtered by
selecting the peptide with the highest Mascot score among peptides
with the same identification. Filtered data were subjected to manual
validation using Qual Browser version 2.0.7 (ThermoFisher Scientific).
Peptides (aa 27–40) containing modifications on Lys-27 or Lys-36
were manually quantified using the Qual Browser. Extracted ion chro-
matograms were constructed for each precursor m/z value with a
mass tolerance of 20 ppm and mass precision up to four decimal
places. Peak areas for a pair of heavy and light peptides were mea-
sured for the same retention time interval. The ratio between the sum
of the peak areas from all H3.2 light peptides (aa 27–40) versus the
sum of all H3.2 heavy peptides (aa 27–40) was close to 1 (1.0). Also,
the SILAC ratios of unmodified peptides (H3.2 and H3.3, aa 53–63)
were between 1.1 and 1.2 in the analysis using the four different
LC-MS/MS methods. The reproducibility of the determined SILAC
ratios over the four different LC-MS/MS methods is shown for two
H3.2 peptides (aa 27–40), Kme2SAPATGGVKme2KPHR and
Kme3SAPATGGVKme2KPHR, in supplemental Fig. 1.
Immunoprecipitation and Western Blotting—RP-HPLC-purified H3
from mouse ESCs was resuspended in binding buffer (25 mM Tris-
HCl, pH 7.6, 150 mM NaCl, 5% glycerol, 0.1% Igepal) and incubated
for 2 h with protein A-Sepharose beads (Amersham Biosciences)
precoupled with H3- and H3K27me2-specific antibodies. Beads were
washed six times with binding buffer, and bound proteins were eluted
from beads by denaturation at 100 °C for 10 min in Laemmli sample
buffer. Eluted proteins were analyzed by standard Western blot anal-
yses using the indicated antibodies.
Antibodies—H3K27me1 (Upstate 07-448), H3K27me2 (Cell Signal-
ing Technology 9728), H3K27me3 (Cell Signaling Technology 9733S),
H3K27Ac (Upstate 07–360), H3K36me2 (Cell Signaling Technology
2901), and H3 (Abcam ab1791) antibodies were used.
RESULTS
Mapping Post-translational Modifications of H3.2 and H3.3
in Mouse ESCs—We isolated histones from wild type and
Suz12-deficient ESCs (Fig. 1A) using a commercially available
purification kit. This method allowed efficient and fast purifi-
cation of linker and core histones. The histone preparations
were then separated by RP HPLC, and the fractions contain-
ing histones H3.2 (Swiss-Prot accession number P84228) and
H3.3 (Swiss-Prot accession number P84244) were digested
with endoproteinase Arg-C. This protease cleaves at the am-
ide bond C-terminal to arginine residues and generates pep-
tides that may contain multiple lysine residues. In histones,
lysine residues frequently carry post-translational modifica-
tions, such as acetyl and methyl groups, which are reversible
and dynamic marks involved in protein-protein and protein-
DNA interactions in chromatin. The peptides were analyzed
by nanoliter flow HPLC interfaced to ESI-MS/MS using an
LTQ-Orbitrap XL mass spectrometer. A long capillary C18
column (25 cm) in combination with a shallow gradient of
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the organic mobile phase (0.22–0.38% solvent B/min) was
used to be able to efficiently separate near identical or iso-
baric modified peptides prior to MS analysis. Four separate
LC-MS/MS methods were used to analyze each sample, all of
them utilizing the high mass accuracy orbitrap analyzer for
peptide mass determination, either CID or ETD for ion frag-
mentation, and either the low mass accuracy LTQ or high
mass accuracy orbitrap analyzer for MS/MS analysis. This
comprehensive LC-MS/MS analysis allowed sequencing of
peptides and localization of distinct, coexisting site-specific
PTMs within these peptides. Applying this approach to his-
tones H3.2 and H3.3, we identified many previously reported
modifications in the N-terminal tails of these proteins (aa
1–50) (Fig. 1, B and C). PTMs that were common to both H3.2
and H3.3 included phosphorylation on Thr-3 and Ser-10;
monomethylation on Lys-4, Lys-9, Lys-18, Lys-27, and Lys-
36; dimethylation on Lys-9, Arg-26, Lys-27, and Lys-36; tri-
methylation on Lys-4, Lys-9, and Lys-27; and acetylation on
Lys-9, Lys-14, Lys-18, Lys-23, and Lys-27. Modifications
found only in H3.2 included acetylation on Lys-4 and dimeth-
ylation on Lys-18. Modifications found exclusively in H3.3
included dimethylation on Lys-4, trimethylation on Lys-36,
and acetylation on Lys-36.
Upon histone sequence database searching and manual
interpretation and verification of the MS/MS data, all identified
peptides were reduced to a list of unique peptides, each
containing no, one, or several modifications. In total, 43 and
38 unique peptides originating from H3.2 and H3.3 samples,
respectively, were characterized (supplemental Table 1,
supplemental Figs. 3–54, and Figs. 2C, 3C, and 4, C–F). Fig.
2, A and B, show a number of unique H3.2 peptides identified
by four different LC-MS/MS methods: CID-Hi/Low, CID-Hi/Hi,
ETD-Hi/Low, and ETD-Hi/Hi. Using CID MS/MS, 23 peptides
in total were sequenced and assigned using the Hi/Low
mode, whereas 19 peptides were assigned by using the Hi/Hi
mode. Using ETD MS/MS, 29 peptides were sequenced and
assigned by the Hi/Low mode, whereas 20 identifications
were obtained by the Hi/Hi mode. The two modes of MS and
MS/MS operation generated overlapping data sets, and it is
clear that the benefit of using the Hi/Hi mode rather than the
Hi/Low mode is limited to peptides with near isobaric co-
existing modifications, regardless of the choice of ion dis-
sociation method. Thus, a majority of the peptides were
confidently sequenced and annotated by taking advantage
of high mass accuracy MS (6-ppm mass error) obtained
by the orbitrap analyzer followed by sensitive but low mass
accuracy MS/MS (0.8-Da mass error) using the LTQ ana-
lyzer. The Hi/Hi mode of operation is very helpful for site-
specific assignment of near isobaric modifications such as
trimethylation and acetylation because the mass difference
FIG. 1. A, quantitative mass spectrometry strategy for histone modifications. Wild type and Suz12-deleted mouse ESCs were grown in the
medium containing normal lysine (Lys0) and stable isotope-labeled lysine (Lys8), respectively. Combined intact histones were separated using
RP HPLC. Aliquots of intact histones or independently prepared histones were used for Western blotting assays. Histones H3.2 and H3.3 were
digested by using endoproteinase Arg-C, and the peptides were analyzed by LC-MS/MS using an 25-cm capillary RP HPLC column
interfaced to the nano-ESI source of an LTQ-Orbitrap XL instrument. B and C, summary of PTMs that were mapped onto the N-terminal tails
of histones H3.2 and H3.3 from mouse ESCs. Most of the previously reported PTMs on H3.2 and H3.3 were identified in the present study.
One circle, monomethylation; two circles, dimethylation; three circles, trimethylation; triangle, acetylation; star, phosphorylation.
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between an acetyl and a trimethyl group is only 0.036 Da.
For example, the H3 (aa 3–17) peptide contained three
lysine residues and two arginine residues, and the mea-
sured mass corresponded to the histone peptide containing
one acetylation, one phosphorylation, and three methyla-
tions (Fig. 2C). To determine which lysine residues were
modified, the peptide precursor ion was fragmented by ETD
in the LTQ analyzer, and the peptide fragment ions were
analyzed in the orbitrap. Interpretation of the resulting ETD
MS/MS spectrum allowed annotation of coexisting modifi-
cations “H3K9me3/S10ph/K14ac” with an average mass
error of 2.46 ppm (S.D.  0.76). The alternative combination
of modified residues “H3K9ac/S10ph/K14me3” exhibited a
larger average mass error of 9.81 ppm (S.D.  32.63) of the
peptide fragment ions. We have previously reported an
algorithm that takes advantage of the high mass accuracy
MS/MS information to assign PTMs (35).
Next, we evaluated the performance of CID and ETD for
peptide sequencing and annotation of PTMs. For CID MS/
MS, the precursor ion charge state was 2 or higher,
whereas for ETD, the precursor ion charge state was 3 or
higher. Note also that the MS/MS duty cycle is slightly
different for these modes of operation (see “Experimental
Procedures”). For histone H3.2, in total 25 unique peptide
identifications were obtained from CID experiments,
whereas 31 unique identifications were obtained from ETD
experiments (Fig. 3A). Thirteen peptides were identified by
both methods. In the case of histone H3.3, 28 peptide
assignments were made by CID experiments, whereas 27
peptide assignments were obtained from ETD experiments
(17 peptides were in common) (Fig. 3B). These results sug-
gested that the application of both CID and ETD MS/MS
leads to a higher number of annotated peptides as com-
pared with using any one of these dissociation methods.
Notably, a nearly 10-fold higher number of phosphopep-
tides were identified using ETD MS/MS as compared with
CID MS/MS. This is partially because of the instability of
phosphoserine/threonine peptide ions in CID MS/MS in ion
trap analyzers. In contrast, such phosphopeptides often gener-
ate useful fragments in ETD MS/MS and allow unambiguous
assignment of phosphorylation sites in peptides. For example,
the peptide aa 3–17 TKQTARKme2SphTGGKacAPR (m/z
434.9827, 4) was sequenced and annotated by ETD MS/MS
(Fig. 3C, upper panel). The fragment ions covered most of the
amino acid sequence, and the phosphate group remained intact
so a combination of modifications “K9me2/S10ph/K14ac”
could be confidently localized. The corresponding CID MS/MS
spectrum (m/z 434.9825, 4) (Fig. 3C, lower panel) generated
a complementary but incomplete y-ion series and signals
that exhibited the neutral loss of H3PO4 or H2O from the
peptide fragments ion. In summary, our MS/MS results
obtained from modified peptides derived from histones
H3.2 and H3.3 are consistent with previous reports that ETD
is advantageous for site-specific mapping of labile modifi-
FIG. 2. MS/MS analysis of histone peptides. The Venn diagrams display the number of observed modified unique H3.2 peptides with one
or several PTMs using CID MS/MS (A) or ETD MS/MS (B). The Hi/Low mode generated more peptide identifications than the Hi/Hi mode for
both ETD and CID MS/MS. C, annotation of coexisting PTMs by using high mass accuracy orbitrap ETD MS/MS (Hi/Hi). Upper panel, ETD
MS/MS spectrum of the H3.3 peptide aa 3–17 TKQTAR(Kme3)(Sph)TGG(Kac)APR (m/z 584.3137, 3). Lower panel, the distribution of
fragment ion mass errors (ppm) for the annotated peptide.
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cations such as phosphorylation on serine, threonine, and
histidine residues (36, 37).
Detailed Analysis of Peptides Containing Modifications on
Lys-27 and Lys-36—We applied CID and ETD MS/MS to
obtain a detailed map of the PTMs in the region that contained
the lysine residues Lys-27 and Lys-36 of histones H3.2 and
H3.3. We detected distinct combinations of methylation (me1,
me2, and me3) and/or acetylation on Lys-27 and/or Lys-36 in
the peptide spanning aa 27–40 (Fig. 4, A and B). K27me1 was
observed alone or in combination with K36me2. K27me2 was
detected either alone or with K36me1 or K36me2 (Fig. 4C).
K27me3 was observed alone or together with K36me2 (Fig.
4D). K27ac was observed with unmodified Lys-36 or various
Lys-36 modifications (me1, me2, and ac) (Fig. 4, E and F).
K36me2 was observed with unmodified Lys-27 or different
types of Lys-27 modifications (me1, me2, me3, and ac). More-
over, the diacetylated peptide K27ac/K36ac was detected for
the first time and sequenced by MS/MS of the H3.3 peptide
from the control ESC samples.
Quantitative Analysis of Histone H3.2 and H3.3 Peptides
Containing Lys-27 and Lys-36—SUZ12 is a component of the
PRC2 complex that catalyzes methylation of H3K27. We in-
vestigated the implications of deleting Suz12 on the PTM
status of the lysine residues Lys-27 and Lys-36 of H3.2 and
H3.3 in mouse ESCs. Pasini et al. (29) showed that the abun-
dance of both H3K27me2 and H3K27me3 was decreased by
deletion of Suz12. We initially confirmed this in the present
study by using Western blotting to demonstrate that SUZ12
activity is effectively ablated in our Suz12 KO ESCs as com-
pared with the control ESCs (Fig. 5C). We then applied SILAC
and mass spectrometry to obtain quantitative data on unmod-
ified and site-specifically modified histone peptides, including
FIG. 3. ETD and CID MS/MS identified histone peptides with a single or coexisting post-translational modifications. The Venn
diagrams display the number of unique identified peptides of H3.2 (A) and H3.3 (B) by CID MS/MS (precursor ion charge state, 1) and ETD
MS/MS (precursor ion charge state, 2). C, ETD MS/MS spectrum of a phosphopeptide. The H3.2/H3.3 peptide (aa 3–17)
TKQTAR(Kme2)(Sph)TGG(Kac)APR (m/z 434.9827, 4) was identified by ETD MS/MS (upper panel). For comparison, the corresponding CID
MS/MS spectrum (m/z 434.9825, 4) is also shown. The underlined amino acids are potentially modified with phosphorylation (Ser and Thr),
dimethylation (Lys), or monomethylation (Lys).
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coexisting PTMs on Lys-27 and Lys-36. We focused our
analysis on the H3.2 and H3.3 peptides spanning aa 27–40 as
they contain a single PTM or a combination of PTMs including
the residue Lys-27, which is the substrate site for the PRC2.
As mentioned previously, endoproteinase Arg-C generated
the appropriate digestion product covering aa 27–40; i.e. no
missed cleavage products originating from this part of the
histone sequence were detected by LC-MS/MS.
Quantitative mass spectrometry results obtained by SILAC
and LC-MS/MS for aa 27–40 peptides from H3.2 and H3.3 are
summarized in Fig. 5A. Representative MS and MS/MS spectra
of modified histone peptides are shown in Fig. 4, C–F, including
H3.3 (aa 27–40) peptides Kme2SAPSTGGVKme2KPHR (Fig.
4C), Kme3SAPSTGGVKme2KPHR (Fig. 4D), KacSAPSTGGVK-
me2KPHR (Fig. 4E), and KacSAPSTGGVKacKPHR (Fig. 4F).
The relative abundance of these modified peptides was ob-
tained from the chromatographic peak area of SILAC-encoded
peptide ion pairs and allowed comparison of wild type (light) and
Suz12-deficient ESCs (heavy) (Fig. 4, C–F, insets). The K27me3
mark accompanied by K36me2 was decreased in Suz12 KO
ESCs (Fig. 4D, inset). K27me2-containing peptides were ac-
companied by K36me2 or unmodified K36. The abundance of
peptides with K27me2/K36me2 (Fig. 4C, inset) marks or
K27me2/K36(unmodified) marks was decreased to a lesser
FIG. 4. Identification of distinct peptide species (aa 27–40) with one or more coexisting PTMs at Lys-27 and/or Lys-36. The tables
display the combinations of modifications that were observed at Lys-27 and Lys-36. All identified unique H3.3 (A) and H3.2 (B) peptides from
MS/MS are marked with “X” on the matrixes. The (X) indicates that peptides were not confirmed by MS/MS, but ion signals from the
corresponding peptides were observed in the MS spectra. C, identification of the H3.3 peptide containing the K27me2/K36me2 mark by ETD
MS/MS (Hi/Hi) of the triply charged precursor ion (m/z 502.6335). D, identification of the H3.3 peptide containing the “K27me3/K36me2” mark
by ETDMS/MS (Hi/Low) of the triply charged precursor ion (m/z 507.3048). E, identification of the H3.3 peptide containing the “K27ac/K36me2”
mark by CID MS/MS (Hi/Hi) of the doubly charged precursor ion (m/z 760.4384). F, identification of the H3.3 peptide containing the
“K27ac/K36ac” mark by ETD MS/MS (Hi/Low) of the triply charged precursor ion (m/z 511.9530). C–F, insets, SILAC peptide ion pairs used
for quantification are labeled: the filled circle is wild type (light isotope version), and the empty circle is Suz12/ (heavy isotope version).
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extent than that of peptides with K27me3/K36me2. These
results are in agreement with the previous report of de-
creased abundance of H3K27me2 and H3K27me3 upon
Suz12 deletion (29). The abundance of K27me2 peptides
decreased to a different degree depending on the modifi-
cation status of Lys-36 upon Suz12 deletion. For example,
peptides containing K27me2/K36me2 decreased by 4-fold,
whereas K27me2/K36(unmodified) peptides decreased 2-
fold upon Suz12 deletion. Interestingly, the abundance of
H3K27ac peptides was increased upon Suz12 deletion re-
gardless of the nature of the modifications on Lys-36 (Fig. 4,
E and F, insets, and Fig. 5, A and D).
We were able to quantify several near identical, isobaric
modified peptides, i.e. peptides with identical molecular
masses that contain identical modifying moieties that are
located at different amino acid residues. For instance, the
peptide (aa 27–40) from H3.3 contains three lysine residues,
Lys-27, Lys-36, and Lys-37, among which two are known to
be methylated. Isobaric peptides often coelute during HPLC,
or they elute within a very short retention time window during
LC-MS/MS analysis. We utilized a shallow LC gradient and a
relatively long (25-cm) chromatographic column to achieve
higher chromatographic resolution (“Experimental Proce-
dures”). Thus, isobaric peptides (aa 27–40) from H3.3 that
were dimethylated at either Lys-27 or Lys-36 were separated,
quantified, and sequenced by LC-MS/MS. The K36me2 pep-
tide eluted first followed by the K27me2 peptide (Fig. 6).
Efficient separation in combination with SILAC facilitated the
determination of the relative abundance of these highly similar
peptide species. The relative abundance of K36me2 in-
creased upon Suz12 deletion, whereas the relative abun-
dance of K27me2 decreased (Fig. 6). Because these modifi-
cations are of biological interest, it is extremely useful to be
able to quantify and characterize these peptides separately.
Western blotting results obtained for distinct Lys-27 mod-
ifications (H3K27me1, H3K27me3, and H3K27ac) agreed
with our quantitative mass spectrometry results (Fig. 5,
B–D). We noted that the Western blotting results obtained
by using a monoclonal antibody directed toward H3K36me2
showed that H3K36me2 levels were similar between Suz12
KO and control ESCs (Fig. 5E). However, quantitative mass
spectrometry produced a more detailed profile of distinct
FIG. 5. Quantification of distinct H3.2 and H3.3 peptides (aa 27–40). A, SILAC-based relative quantification of H3.2 and H3.3 peptides.
Peptides containing the K27me2 and K27me3 marks decreased in abundance, whereas peptides containing the K27ac mark increased in
abundance upon Suz12 deletion. Error bars indicate the S.D. calculated from the technical replicates. B–E, Western blotting results using
monoclonal antibodies against H3K27me1 (B), H3K27me3 (C), H3K27ac (D), and H3K36me2 (E). H3 (H3 C terminus) was used as a loading control.
WT, wild type.
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K36me2 peptides: K36me2 in combination with either
K27me2 or K27me3 decreased upon Suz12 deletion,
whereas H3K36me2 alone or in combination with H3K27ac
increased in relative abundance (Figs. 4, C–E, and 5A).
These results highlight the advantages and the importance
of using unbiased quantitative mass spectrometry for mon-
itoring coexisting transient and dynamic PTMs in proteins.
There is an obvious risk of missing detailed quantitative
information on coexisting and cooperative PTMs when
solely relying on Western blotting for the detection of indi-
vidual PTMs in histone proteins.
Global Isoform Quantification of Lys-27/Lys-36-modified
Peptides—The SILAC-based quantitative mass spectrometry
analysis revealed distinct features of individual modified his-
tone peptide species. We also aimed at getting an overall view
on the relative abundance profile for unmodified and modified
peptides corresponding to aa 27–40, particularly the modifi-
cation states of the Lys-27/Lys-36 residues and how this
profile changed upon deletion of Suz12 in mouse ESCs. A
global isoform quantification method (38, 39) was adapted to
our data set. For each unique peptide, the global isoform
percentage (GP) was calculated according to the following
equation.
GP (%)

Peak area for each isoform 100
Sum of peak area from all observed light (or heavy) isoforms
(Eq. 1)
The GP value for a specific peptide species represents the
relative proportion of that peptide isoform/variant among all
quantified peptide species sharing the same amino acid se-
FIG. 6. Separation, sequencing, and quantification of isobaric modified peptides. The extracted ion chromatograms of the doubly
charged precursor ion (m/z 739.4333) from the “light” dimethylated peptide H3.3 KSAPSTGGVKKPHR (aa 27–40) (upper) and the correspond-
ing “heavy” peptide m/z 751.4544 (2) (lower). Separation of these isobaric modified peptides allowed quantification of the two different
dimethylated peptide species. The dimethylated peptide “KSAPSTGGVKme2KPHR” eluted prior to the isobaric dimethylated peptide
“Kme2SAPSTGGVKPHR.” The filled circle is wild type (light isotope version), and the empty circle is Suz12/ (heavy isotope version).WT, wild
type.
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quence. For H3.2 and H3.3 peptides covering the amino acids
27–40, a total of 11 unique peptide species were quantified.
GP analysis of these peptides showed that peptides contain-
ing “K27me2/K36me2” marks were predominant in H3.2 as
well as H3.3 from wild type ESCs (Fig. 7). This result was
confirmed by antibody-based assays (immunoprecipitation
and Western blotting) (Fig. 7, inset). Higher amounts of
H3K36me2 were observed by Western blots of H3K27me2
pulldowns as compared with H3 (C-terminal) pulldowns.
Upon Suz12 deletion, peptides containing K36me2 (no mod-
ification of Lys-27) were the dominant structure for both H3.2
and H3.3 (Fig. 7), again demonstrating H3K27-directed methyl-
transferase activity of the PRC2. In general, K27ac peptides
were of rather low abundance as compared with K27me or
unmodified Lys-27 peptides in both wild type and Suz12 KO
ESCs. When all quantified isoforms were categorized according
to the Lys-27 modifications (none, me2, and ac), each Lys-27
modification accompanied by K36me2 was most abundant
(supplemental Fig. 2). Thus, the GP analysis revealed additional
features of the PTM profiles of aa 27–40 peptides from histones
H3.2 and H3.3, i.e. features that were missing from the peptide-
centric SILAC-based quantification. The combination of pep-
tide-centric relative quantification by SILAC with the “peptide
family” relative quantification by GP contributed toward a more
detailed interpretation of histone PTMs.
DISCUSSION
The histone modification status influences the transcrip-
tional activity of genes, for example by inducing structural
changes in chromatin or by creating docking sites for chro-
matin-binding effector proteins. Acetylation of lysine residues
of histones is mainly linked to transcriptional activation of
genes, whereas methylation of specific lysine residues, such
as H3K27 and H3K9, is associated with repression of tran-
scription. Coexisting PTMs, PTM cross-talk, and cooperativity
of PTMs in protein molecules are of immense importance for
the biological activity in cells, tissues, and organisms (14, 40).
Thus, by interfering with or by perturbing specific enzymes
that modify histones at particular amino acid residues, it is
likely that “ripple effects” will be observed, i.e. alterations of
modification occupancy at different, adjacent, or remote
amino acid residues in the same protein or in closely associ-
ated, interacting proteins.
In the present study, we applied quantitative mass spec-
trometry for mapping and characterization of coexisting PTMs
on histones H3.2 and H3.3 from wild type and Suz12 KO
ESCs (Fig. 1A). Intact H3 variants were separated by RP
HPLC and digested using endoproteinase Arg-C. Peptide
mixtures were analyzed by four different LC-MS/MS methods
using LTQ-CID/ETD-orbitrap technology. The high mass ac-
curacy and mass resolution achieved by the orbitrap MS
combined with sensitive LTQ MS/MS or accurate orbitrap
MS/MS allowed the annotation of acetylated, methylated, and
phosphorylated histone peptides. A majority of the known
PTMs on mammalian H3.2 and H3.3 were observed (Fig. 1, B
and C, supplemental Table 1, and supplemental Figs. 3–54),
supporting the efficiency, sensitivity, and specificity of our
analytical strategy.
FIG. 7. GP profile of histone peptides (aa 27–40). Peptides containing the K27me2/K36me2 marks were the most abundant species in
histones H3.2 and H3.3 from wild type mouse ESCs. Peptides that exclusively contained K36me2 were most abundant in H3.2 and H3.3 upon
Suz12 deletion. Inset, histone detection by immunoprecipitation followed by Western blotting of histones purified from wild type mouse ESCs.
A higher abundance of H3K36me2 was observed by Western blotting of H3K27me2 pulldowns as compared with the H3 (C-terminal)
pulldowns. Error bars indicate the S.D. calculated from the technical replicates.
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Endoproteinase Arg-C was used in this study instead of the
more commonly used enzyme trypsin. Digestion of lysine-rich
histone proteins with trypsin, endoproteinase Lys-C, or other
enzymes that cleave at unmodified lysine residues would have
generated many small peptides that are likely to be missed
during LC-MS/MS analysis. Endoproteinase Arg-C cleaves
only after arginine; hence, it generates longer peptides than
trypsin or endoproteinase Lys-C, and it allows quantitative
analysis of lysine-containing peptides by mass spectrometry,
including acetylated and methylated lysine residues.
LC-MS/MS analysis of H3.2 and H3.3 digested with endo-
proteinase Arg-C resulted in identification of 43 and 38 unique
modified peptides from H3.2 and H3.3, respectively. A major-
ity of modified peptides were found from the peptides aa
3–17, aa 9–17, and aa 27–40. Various isoforms were identi-
fied from the region aa 27–40 containing different modifica-
tions (none, me1, me2, me3, and ac) at Lys-27 and/or Lys-36
(Fig. 4, A and B). Combinations of PTMs between Lys-27 and
Lys-36 were previously observed in HeLa cells (21, 41) except
for the H3K36ac species that we report in the present study.
A number of putative peptide species (aa 27–40) containing
K27me1/K36me1, K27me3/K36me1, K27me1/K36me3,
K27me2/K36me3, K27me3/K36me3, and K27ac/K36me3
went undetected, possibly because of limitations of our ana-
lytical strategy, the very low abundance of these species, or
the fact that histones H3.2 and H3.3 from mouse ESCs may
lack these combinations of PTMs.
We report for the first time the co-occurrence of H3K27ac/
K36ac in mammalian ESCs. This combination was previously
only observed in histones obtained from unicellular orga-
nisms, i.e. Tetrahymena thermophila and Saccharomyces cer-
evisiae (42). H3K36ac has been suggested to be involved in
RNA polymerase II-mediated gene transcription (42). We2 and
others (43) have recently shown that H3K27ac is associated
with transcriptional activation of polycomb group target
genes. Thus, the combination of K27ac and K36ac might
constitute an “amplifier” that reinforces transcriptional activa-
tion in a cooperative manner, much like the coexisting
H3K9ac and H3K14ac marks.
We analyzed histone peptides using four different LC-
MS/MS methods: CID fragmentation followed by an MS/MS
scan using the LTQ (CID-Hi/Low) or the orbitrap (CID-Hi/Hi) or
ETD fragmentation followed by an MS/MS scan using the LTQ
(ETD-Hi/Low) or the orbitrap (ETD-Hi/Hi). In most cases, the
Hi/Low scan mode was sufficient for sequencing peptides
and mapping site-specific PTMs (Fig. 2, A and B). The Hi/Hi
scan mode suffered from relatively poor ion transmission and
reduced duty cycle because ions had to be transferred from
the LTQ to the orbitrap for the high mass resolution detection
in MS/MS mode. This may be a limitation of the LTQ-Orbitrap
XL system used in our study. The recently introduced LTQ-
Orbitrap Velos instrument has an improved trapping and
transfer geometry that facilitates a higher duty cycle and more
efficient ion transmission that will benefit the Hi/Hi mode of
operation. Nevertheless, Hi/Hi mode was useful for mapping
near isobaric coexisting modifications on multiple candidate
PTM substrate sites because of the high mass accuracy de-
termination of fragment ions (Fig. 2C).
We used two different dissociation methods, ETD and CID,
to identify as many modified peptides as possible. Indeed, the
overall number of identified unique peptides was increased as
compared with analyzing samples only by one of the disso-
ciation methods (Fig. 3, A and B) as also reported by others
(44). In particular, ETD MS/MS was efficient for detecting a
combination of PTMs bearing phosphorylations (Fig. 3C). CID
and ETD MS/MS experiments were performed for different
charge states of peptides (“Experimental Procedures”). Thus,
the results of CID MS/MS and ETD MS/MS experiments are
not directly comparable because the fragmentation efficiency
of CID and ETD depends on many parameters such as them/z
value, the charge state, and the amino acid composition of
peptide ions. In addition, minor variations in the LC separation
and the data-directed method for MS/MS of peptides lead to
variability. Nevertheless, using both ETD and CID MS/MS
extended peptide identifications, achieving comprehensive
mapping of PTMs.
The effect of Suz12 deletion was studied by a quantitative
proteomics approach using SILAC and LC-MS/MS analysis.
Upon Suz12 deletion, we detected a relative decrease of
H3K27me2 and H3K27me3 and an increase of H3K27ac
(Figs. 4, C–F, and 5A), thereby identifying an antagonistic
Lys-27 methyl/acetyl switch. At the same time, we determined
the modification status of Lys-36, thereby revealing distinct
relationships between Lys-27 and Lys-36 modifications.
Increased acetylation on H3K27 upon Suz12 deletion is in
accordance with a very recent study that demonstrated an
increase in the abundance of H3K27ac upon knockdown of
Su(z)12 or the catalytic subunit of PRC2, E(Z), which are ortholo-
gous to mammalian Suz12 and Ezh2 in Drosophila (43). Thus,
depletion of methylation at H3K27 by knocking out the Ezh2 or
the Suz12 component of the PRC2 leads to antagonistic acety-
lation of H3K27. A more detailed characterization of the func-
tional role of H3K27ac in regulating polycomb group target gene
expression in mouse ESCs will be described separately.2
The mass spectrometry data provided a much more de-
tailed overview of the modification profiles of Lys-27/Lys-36
than was possible with standard Western blotting ap-
proaches. For example, K36me2 was identified with
K27(unmodified) and K27me1, -me2, -me3, and -ac. K27me2/
K36me2-containing peptides decreased to a lesser extent
than K27me3/K36me2 peptides upon Suz12 deletion. K27/
K36me2 and K27ac/K36me2 peptides were increased upon
Suz12 deletion. In contrast, the Western blotting result indi-
cated that H3K36me2 was present at approximately the same
2 D. Pasini, M. Malatesta, H. R. Jung, J. Walfridsson, A. Willer, L.
Olsson, J. Skotte, A. Wutz, O. N. Jensen, and K. Helin, submitted
manuscript.
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level in wild type and Suz12 KO ESCs (Fig. 5E). These obser-
vations clearly indicate that Western blotting results that are
targeted toward one specific type of PTM have to be carefully
interpreted as they may miss important regulatory features
that involve multiple, coexisting PTMs. Clearly, mass spec-
trometry is much better suited to detect and quantify coex-
isting PTMs in peptides and proteins.
We found that it is important to be able to separate isobaric
peptides by LC prior to the MS analysis (Fig. 6) because this
allows accurate quantitative analysis of related peptide spe-
cies by SILAC and GP. Using a long capillary RP HPLC
column and a shallow gradient of organic mobile phase, iso-
baric modified peptides were separated and subsequently
quantified by MS and sequenced by MS/MS. Obviously, some
low abundance isobaric peptides will be missed because only
the most abundant peptide ions are selected for sequencing
by data-directed MS/MS approaches.
The GP approach allowed us to estimate the relative abun-
dance profiles of modified peptide species and showed that
peptides containing the K27me2/K36me2 marks were the
predominant species (55–62%) among all observed H3.2 and
H3.3 (aa 27–40) peptides from control ESCs (Fig. 7). This is in
excellent agreement with a report demonstrating that the
K27me2 species is the most abundant (50%) of all Lys-27
species (none, me1, me2, and me3) in mouse ESCs (45).
We found relatively high amounts of H3.3K27me3 (10%) in
wild type ESCs, which is possibly due to the wide distribution
of H3K27me3 across promoter, protein coding, and intergenic
regions (46, 47). In fact, the GP value of the H3.3K27me3/
K36me2 marks in our study agrees with a recent report that
H3K27me3 covered 11% of chromosome 17 in mouse em-
bryonic fibroblast (47). Furthermore, the GP value of K27me2/
K36me2 remained relatively high (12%) despite deletion of
Suz12. This might suggest that a hitherto undiscovered meth-
yltransferase, in addition to PRC2, can catalyze dimethylation
of H3K27 in mammalian ESCs.
In conclusion, quantitative mass spectrometry applied to
the identification and quantification of H3.2 and H3.3 revealed
most of the known PTMs in wild type and Suz12 KO mouse
ESCs. Unique peptides with distinct coexisting PTMs were
annotated and quantified, revealing novel features of histone
marks at Lys-27 and Lys-36 in the context of PRC2 function
and ablation of Suz12. The analytical and computational work
flow presented here is suitable for general studies of dynamic
coexisting PTMs in proteins to elucidate the effects of envi-
ronmental, genetic, biochemical, and pharmacological pertur-
bations in cells and organisms.
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